Transients of delayed fluorescence induction signal and photosynthetic antennas: A possible relationship. Mathematical modeling approach

2006 ◽  
Vol 53 (3) ◽  
pp. 289-297 ◽  
Author(s):  
A. Kalauzi ◽  
D. Z. Marković ◽  
Č. N. Radenović
Author(s):  
Cedomir Radenovic ◽  
Aleksandar Kalauzi ◽  
Kosana Konstantinov ◽  
Goran Drinic

A mathematical model was developed for resolved temporal transients of experimentally recorded delayed fluorescence (DF) induction signal. During an intermittent light regime, antennas of the photosynthetic apparatus were treated as targets, repeatedly hit by potentially absorbable photons within a series of consecutive light flashes. Formulas were derived for the number of antennas, cumulatively hit by a specific number of photons, as function of the flash serial number (time). Model parameters included: number of absorbable photons in one flash, antenna sizes and numbers. A series of induction curves were analyzed, obtained from a ZeamaysL. leaf segment and differing in the previous dark period (td). Each curve, consisting of the two most prominent DF transients (C and D), was fitted with several model types, differing in the number of absorbed photons. For both transients, the best fitting result was achieved when DF induction was linked to the second absorbed photon. As expected, model parameters related to antenna sizes showed weaker dependence on td than those referring to antenna numbers. With restrictions applied in this model, the two DF induction transients may be related to two classes of photosynthetic antennas. Their different sizes may have a predominant influence on the efficiency of photon absorption, and possibly time-dependent appearance of DF transients.


2021 ◽  
pp. 107140
Author(s):  
Iulia Martina Bulai ◽  
Ana Cristina Esteves ◽  
Fernanda Lima ◽  
Ezio Venturino

2021 ◽  
Author(s):  
Javier C. Urcuyo ◽  
Susan Christine Massey ◽  
Andrea Hawkins-Daarud ◽  
Bianca-Maria Marin ◽  
Danielle M. Burgenske ◽  
...  

AbstractGlioblastoma is the most malignant primary brain tumor with significant heterogeneity and a limited number of effective therapeutic options. Many investigational targeted therapies have failed in clinical trials, but it remains unclear if this results from insensitivity to therapy or poor drug delivery across the blood-brain barrier. Using well-established EGFR-amplified patient-derived xenograft (PDX) cell lines, we investigated this question using an EGFR-directed therapy. With only bioluminescence imaging, we used a mathematical model to quantify the heterogeneous treatment response across the three PDX lines (GBM6, GBM12, GBM39). Our model estimated the primary cause of intracranial treatment response for each of the lines, and these findings were validated with parallel experimental efforts. This mathematical modeling approach can be used as a useful complementary tool that can be widely applied to many more PDX lines. This has the potential to further inform experimental efforts and reduce the cost and time necessary to make experimental conclusions.Author summaryGlioblastoma is a deadly brain cancer that is difficult to treat. New therapies often fail to surpass the current standard of care during clinical trials. This can be attributed to both the vast heterogeneity of the disease and the blood-brain barrier, which may or may not be disrupted in various regions of tumors. Thus, while some cancer cells may develop insensitivity in the presence of a drug due to heterogeneity, other tumor areas are simply not exposed to the drug. Being able to understand to what extent each of these is driving clinical trial results in individuals may be key to advancing novel therapies. To address this challenge, we used mathematical modeling to study the differences between three patient-derived tumors in mice. With our unique approach, we identified the reason for treatment failure in each patient tumor. These results were validated through rigorous and time-consuming experiments, but our mathematical modeling approach allows for a cheaper, quicker, and widely applicable way to come to similar conclusions.


Sign in / Sign up

Export Citation Format

Share Document